WEEKLY PACLITAXEL (W-PAC) AS SECOND-LINE THERAPY IN CISPLATIN PRETREATED PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles